# Luminous Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/luminous-medical

- Industry: Medical Devices & Equipment
- Headquarters: Carlsbad, US
- Total disclosed funding: $33M
- Latest round: Series B (Mar 1, 2008)
- Investors on record: 5

## About

Based in California, US, Luminous Medical, Inc. is a healthcare technology company focused on improving patient outcomes through advanced glucose management systems. In December 2010, Luminous Medical Inc. received USD 3.938 million of financing from previous investors Adams Street Partners, Latterell Venture Partners and De Novo Ventures.

The flagship product under development is the Luminous Medical Glucose Monitor (GM). Designed for use in intensive care units (ICU), operating rooms (OR), and intermediate care settings, the GM enables frequent and accurate blood glucose measurements. This investigational device aims to reduce errors, improve safety, and minimize nursing labor while helping clinicians achieve glucose targets effectively.

Luminous Medical’s revenue model is center on the commercialization of its glucose monitoring systems. This includes direct sales to hospitals, licensing of proprietary sensor technology, and potential partnerships with healthcare providers and device manufacturers.

## Funding rounds

- Series B, Mar 1, 2008, $24M — Adams Street Partners, Latterell Venture Partners, RiverVest Ventures Partners, De Novo Ventures, Finistere Ventures
- Series A, Nov 16, 2005, $9M — Latterell Venture Partners, De Novo Ventures

## Investors

- Latterell Venture Partners (https://capitalatlas.ai/funds/latterell-venture-partners) — Series A, Series B
- De Novo Ventures (https://capitalatlas.ai/funds/de-novo-ventures) — Series A, Series B
- Adams Street Partners (https://capitalatlas.ai/funds/adams-street-partners) — Series B
- RiverVest Ventures Partners (https://capitalatlas.ai/funds/rivervest-ventures-partners) — Series B
- Finistere Ventures (https://capitalatlas.ai/funds/finistere-ventures) — Series B